INHA and tuberculosis: According to the vulnerability predictions made by Bosch et al. (2021) (17), the aroG in M. tuberculosis shows a VI of −13.3670 whereas the inhA, which encode the target of the first-line drugs for TB, isoniazid, presents a VI of −9.9130.